Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1528.35 -41.20 (-2.63%) | NSE 1527.80 -47.20 (-3.00%) | Trade | Add

BSE Live

Jan 12, 16:01

1528.35 -41.20 (-2.63%)

Volume

AVERAGE VOLUME

5-Day

41,741

10-Day

25,663

30-Day

31,532

14,151

Prev. Close

1569.55
Open Price

1574.00

Bid Price (Qty.)
1528.35 (2)
Offer Price (Qty.)
1560.00 (5)

NSE Live

Jan 12, 15:58

1527.80 -47.20 (-3.00%)

Volume

AVERAGE VOLUME

5-Day

555,021

10-Day

400,208

30-Day

250,368

568,045

Prev. Close

1575.00
Open Price

1574.00

Bid Price (Qty.)
1527.80 (581)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ipca Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.27	25.27	25.24	25.24	25.24
Total Share Capital	25.27	25.27	25.24	25.24	25.24
Reserves and Surplus	3,640.33	3,111.39	2,669.71	2,449.88	2,257.81
Total Reserves and Surplus	3,640.33	3,111.39	2,669.71	2,449.88	2,257.81
Total Shareholders Funds	3,677.54	3,136.66	2,694.95	2,475.12	2,283.05
NON-CURRENT LIABILITIES
Long Term Borrowings	78.38	133.94	234.01	351.74	484.28
Deferred Tax Liabilities [Net]	140.79	146.26	158.66	168.64	155.64
Other Long Term Liabilities	15.28	1.56	1.56	1.56	1.56
Long Term Provisions	30.98	25.28	25.88	24.55	20.22
Total Non-Current Liabilities	265.43	307.04	420.11	546.49	661.70
CURRENT LIABILITIES
Short Term Borrowings	309.27	195.86	239.04	177.30	182.86
Trade Payables	537.85	464.09	414.75	388.06	415.24
Other Current Liabilities	301.63	283.49	271.65	320.57	299.61
Short Term Provisions	92.85	70.40	67.21	60.41	62.17
Total Current Liabilities	1,241.60	1,013.84	992.65	946.34	959.88
Total Capital And Liabilities	5,184.57	4,457.54	4,107.71	3,967.95	3,904.63
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,798.91	1,706.35	1,816.44	1,899.69	1,927.88
Intangible Assets	42.06	33.75	38.17	46.28	48.70
Capital Work-In-Progress	69.77	35.72	42.02	62.33	93.80
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	1,925.16	1,806.06	1,927.84	2,040.84	2,105.51
Non-Current Investments	410.47	231.86	146.28	98.01	97.43
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	98.98	116.96	110.45	95.31	71.65
Other Non-Current Assets	37.85	17.11	15.97	22.14	30.27
Total Non-Current Assets	2,472.46	2,171.99	2,200.54	2,256.30	2,304.86
CURRENT ASSETS
Current Investments	238.25	90.38	69.35	113.57	0.00
Inventories	1,266.96	1,055.55	873.17	873.54	831.93
Trade Receivables	839.13	632.06	594.38	501.98	441.45
Cash And Cash Equivalents	152.40	259.81	131.03	17.53	161.98
Short Term Loans And Advances	3.22	2.12	2.14	2.03	2.85
OtherCurrentAssets	212.15	245.63	237.10	203.00	161.56
Total Current Assets	2,712.11	2,285.55	1,907.17	1,711.65	1,599.77
Total Assets	5,184.57	4,457.54	4,107.71	3,967.95	3,904.63
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	219.49	164.84	80.65	88.04	116.94
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	234.14
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	2.86
Trade/Other Goods	0.00	0.00	0.00	0.00	2.86
Capital Goods	0.00	0.00	0.00	0.00	45.52
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	769.43	626.64	488.36	457.10	444.53
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	2,143.75	1,730.84	1,564.21	1,561.74	1,429.85
Other Earnings	--	--	--	--	6.61
BONUS DETAILS
Bonus Equity Share Capital	20.90	20.90	20.90	20.90	20.90
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	43.05
Non-Current Investments Unquoted Book Value	--	--	--	0.05	78.10
CURRENT INVESTMENTS
Current Investments Quoted Market Value	238.25	90.38	69.35	113.57	--
Current Investments Unquoted Book Value	--	--	--	--	--